Regional Monitoring EECA
by ECUO PLWH
Showing 1-473 of 473 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of MoldovaGovernmentViiv Healthcare UK LimitedZiagenAbacavir (ABC)20mg/ml oral solution 240ml59.98114159.981146837.72Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
2Russian FederationGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab1.09328209206065.5913682897402.382015Not specifiedNot specifiedNot specified
3UkraineGovernmentViiV HealthcareAbacavir (ABC)20mg/ml oral solution 240ml0.08119101510.08119101595281.22016Not specifiedNot specifiedNot specified
4Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.2333606014114Not specifiedNot specifiedNot specified
5Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml6.75216.75213.5VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
6Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.8125300060228.755011437.5Not specifiedNot specifiedNot specified
7Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml12-112--Not specifiedNot specifiedNot specified
8Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.5100172.51007250Not specifiedNot specifiedNot specified
9Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.540172.5402900Not specifiedNot specifiedNot specified
10Kyrgyz RepublicGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.2125211806012.753534500.75UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
11Russian FederationGovernmentDrugs technologyAbacavir-ABCAbacavir (ABC)300mg tab1.15965521206069.5410920275939072015Not specifiedNot specifiedNot specified
12Republic of KazakhstanGovernmentKievmedpreparat, UkraineAbacavir (ABC)20mg/ml oral solution 240ml119.485961119.4859671210.082015Not specifiedNot specifiedNot specified
13GeorgiaGlobal FundHetero labs Ltd.Abacavir (ABC)20mg/ml oral solution 240ml7.521617.52161620partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
14Republic of LatviaGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.47026060208.211208.21Not specifiedNot specifiedNot specified
15Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)600mg tab2.509760223203075.29200744151140162015Not specifiedNot specifiedNot specified
16Republic of BelarusGlobal FundHetero labs Ltd.Abacavir (ABC)300mg tab0.18482991006011.09498555283.65UNICEF Supply Division20152015-05-24Not specifiedNot specifiedNot specified
17UkraineGovernmentGlaxoSmithKlineAbacavir (ABC)300mg tab0.26828132406016.0913554218083.862016Not specifiedNot specifiedNot specified
18Republic of TajikistanGlobal FundViiV HealthcareAbacavir (ABC)20mg/ml oral solution 240ml8-18--Not specifiedNot specifiedNot specified
19Republic of BelarusGovernmentHetero Labs + ФарматехAbacavir (ABC)300mg tab0.33429008406020.0515014301030.69Фарматех ЗАО2015Not specifiedNot specifiedNot specified
20Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)150mg tab0.6933180606041.630112521.62015Not specifiedNot specifiedNot specified
21Republic of KazakhstanGovernmentMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.04311091600602.58184860476938.812015Not specifiedNot specifiedNot specified
22GeorgiaGlobal FundMYLAN LABORATORIES LTDAbacavir (ABC)300mg tab0.1832129606010.992162373.84partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
23Republic of ArmeniaGlobal FundCipla LtdAbacavir (ABC)300mg tab0.19569006011.71151345.5VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
24UkraineGlobal FundGlaxoSmithKlineAbacavir (ABC)300mg tab0.425606025.5125.52015Not specifiedNot specifiedNot specified
25Republiс of AzerbaijanGovernmentGlaxoSmithKlineAbacavir (ABC)300mg tab0.6048285606036.2947617274.04YesYesNot specified
26Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml72.544172.5443190Not specifiedNot specifiedNot specified
27Russian FederationGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml45.621875145.6218759975002015Not specifiedNot specifiedNot specified
28Republic of LatviaGovernmentViiV HealthcareZiagenAbacavir (ABC)20mg/ml oral solution 240ml66.29-166.29--Not specifiedNot specifiedNot specified
29Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.Abacavir (ABC)20mg/ml oral solution 240ml37.44533137.4453319955.52YesYesNot specified
30Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Abacavir (ABC)300mg tab0.1848606011.09111.09Not specifiedNot specifiedNot specified
31Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.81253900060228.75650148687.5Not specifiedNot specifiedNot specified
32Republic of PolandGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab3.81253000060228.75500114375Not specifiedNot specifiedNot specified
33Russian FederationGovernmentPharmasyntezOlitidAbacavir (ABC)300mg tab1.1333264384060684406429963522015Not specifiedNot specifiedNot specified
34Republic of KazakhstanGovernmentViiV HealthcareZiagenAbacavir (ABC)300mg tab0.0442343600602.6439060103118.42015Not specifiedNot specifiedNot specified
35Kyrgyz RepublicGlobal FundCipla LtdAbamune-L BabyAbacavir+Lamivudine - FDC60mg+30mg tab0.0833282060547235UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
36Republic of TajikistanGlobal FundViiV HealthcareAbacavir+Lamivudine - FDC60mg+30mg tab0.08336060515Not specifiedNot specifiedNot specified
37Republic of MoldovaGlobal FundHetero labs Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.56550403016.951682847.62015Not specifiedYesNot specified
38Russian FederationGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab4.002436197030120.06145399174566042015Not specifiedNot specifiedNot specified
39Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.43331590301353689VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
40Republic of PolandGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.16671800030425600255000Not specifiedNot specifiedNot specified
41Republic of MoldovaGlobal FundCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.1221480607.23582577.62015Not specifiedYesNot specified
42Republiс of AzerbaijanGovernmentViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab1.7167219603051.573237698YesYesNot specified
43UkraineGlobal FundGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab1.02303030.6130.62015Not specifiedNot specifiedNot specified
44Republic of MoldovaGlobal FundHetero labs Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.56550703016.951692864.55IDA Foundation2015Not specifiedYesNot specified
45Republic of LatviaGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.6193030348.571348.57Not specifiedNot specifiedNot specified
46Republic of MoldovaGlobal FundCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.1221060607.23512527.22015Not specifiedYesNot specified
47Republic of TajikistanGlobal FundViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab0.5167303015.5115.5Not specifiedNot specifiedNot specified
48Republic of LithuaniaGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.13733030334.121334.12Viiv Healthcare UK LimitedNot specifiedYesNot specified
49Kyrgyz RepublicGlobal FundAurobindo Pharma Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.5167-3015.5--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
50UkraineGovernmentGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab0.97971719303029.395731168434.092016Not specifiedNot specifiedNot specified
51Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.16671950003042565002762500Not specifiedNot specifiedNot specified
52Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.166766000304252200935000Not specifiedNot specifiedNot specified
53Republic of KazakhstanGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab0.377730474003011.331015801150901.382015Not specifiedNot specifiedNot specified
54UkraineGovernmentCipla LtdAbacavir+Lamivudine - FDC60mg+30mg tab0.097264440605.8310746261.422016Not specifiedNot specifiedNot specified
55Republic of KazakhstanGovernmentViiV HealthcareAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab0.10783877200606.4764620418091.412015Not specifiedNot specifiedNot specified
56Republic of KazakhstanGovernmentViiV HealthcareAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab0.10783600606.4760388.22015Not specifiedNot specifiedNot specified
57Republic of PolandGovernmentViiV HealthcareTrizivirAbacavir+Lamivudine+Zidovudine - FDC300mg+150mg+300mg tab9.791790060587.5158812.5Not specifiedNot specifiedNot specified
58Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.416716200030462.554002497500Not specifiedNot specifiedNot specified
59Republic of BelarusGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.5667432030171442448IDA Foundation20152015-12-222016-04-14NoNoNot specified
60Republic of LatviaGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps13.09573030392.871392.87Not specifiedNot specifiedNot specified
61Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)150mg caps1.7975553782060107.859229799542312015Not specifiedNot specifiedNot specified
62Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps7.51380060450230103500Not specifiedNot specifiedNot specified
63Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.41672700030462.5900416250Not specifiedNot specifiedNot specified
64GeorgiaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.6486003018162029160partnership for supply. chain management (PFSCM)2015NoYesNot specified
65Republic of MoldovaGlobal FundEmcure Pharmaceuticals Ltd.Atazanavir (ATV)300mg caps0.698350103020.951673498.65IDA Foundation2015Not specifiedYesNot specified
66Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)200mg caps2.37471000794060142.48166799237655222015Not specifiedNot specifiedNot specified
67Russian FederationGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps3.60311103030108.093701400041.092015Not specifiedNot specifiedNot specified
68Republic of PolandGovernmentBristol-Myers SquibbReyatazAtazanavir (ATV)300mg caps15.4167300030462.510046250Not specifiedNot specifiedNot specified
69Republic of PolandGovernmentBristol-Myers SquibbEvotazAtazanavir+Cobicistat300mg+150mg tab16.253600030487.51200585000Not specifiedNot specifiedNot specified
70Republiс of AzerbaijanGovernmentCipla LtdAtazanavir+Ritonavir - FDC300mg+100mg tab2.236750403067.116811272.8YesYesNot specified
71Republic of MoldovaGlobal FundHetero labs Ltd.Darunavir (TCM)600mg tab1.8202138060109.21232511.832015Not specifiedNot specifiedNot specified
72GeorgiaGlobal FundJanssenDarunavir (TCM)600mg tab11.61368060696228158688partnership for supply. chain management (PFSCM)2015NoYesNot specified
73Russian FederationGovernmentJanssenPrezistaDarunavir (TCM)400mg tab5.043318060302.585316036.742015Not specifiedNot specifiedNot specified
74Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab14.98546500030449.55155006968025Not specifiedNot specifiedNot specified
75Republic of MoldovaGlobal FundHetero labs Ltd.Darunavir (TCM)600mg tab1.8202864060109.2114415726.24IDA Foundation2015Not specifiedYesNot specified
76Russian FederationGovernmentJanssenPrezistaDarunavir (TCM)800mg tab10.27191091030308.163697196250462015Not specifiedNot specifiedNot specified
77UkraineGovernmentJanssenDarunavir (TCM)600mg tab8.5543140605137193688472016Not specifiedNot specifiedNot specified
78Republic of LatviaGovernmentJanssenPrezistaDarunavir (TCM)600mg tab10.35536060621.321621.32Not specifiedNot specifiedNot specified
79Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)150mg tab2.75631920240661.585292Not specifiedNot specifiedNot specified
80Republic of ArmeniaGlobal FundJanssenDarunavir (TCM)600mg tab11.61806069632088VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
81Russian FederationGovernmentHetero labs Ltd.DarunavirDarunavir (TCM)600mg tab6.55033054060393.02509200047.192015Not specifiedNot specifiedNot specified
82Republic of MoldovaGlobal FundHetero labs Ltd.Darunavir (TCM)600mg tab1.8202726060109.2112113214.412015Not specifiedNot specifiedNot specified
83Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)400mg tab4.604278438060276.25130733611416.252015Not specifiedNot specifiedNot specified
84Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab13.7887650030413.6425501054782Not specifiedNot specifiedNot specified
85Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)800mg tab8.63771587030259.13529137079.772015Not specifiedNot specifiedNot specified
86Republiс of AzerbaijanGovernmentJanssenPrezistaDarunavir (TCM)600mg tab20.566211520601233.97192236922.23YesYesNot specified
87UkraineGovernmentJanssenDarunavir (TCM)400mg tab5.722206034237126542016Not specifiedNot specifiedNot specified
88Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)600mg tab11.0258700060661.51450959175Not specifiedNot specifiedNot specified
89Republic of BelarusGovernmentHetero Labs + ФарматехDarunavir (TCM)600mg tab6.98133168060418.88528221168.64Фарматех ЗАО2015Not specifiedNot specifiedNot specified
90Republic of LatviaGovernmentJanssenPrezistaDarunavir (TCM)400mg tab7.81176060468.71468.7Not specifiedNot specifiedNot specified
91Russian FederationGovernmentPharmasyntezKemeruvirDarunavir (TCM)600mg tab6.8323215754060409.9435959147410322015Not specifiedNot specifiedNot specified
92Republic of PolandGovernmentJanssenPrezistaDarunavir (TCM)800mg tab13.7881365030413.64455188206.2Not specifiedNot specifiedNot specified
93Russian FederationGovernmentJanssenPrezistaDarunavir (TCM)600mg tab7.059544448060423.5774083137806.52015Not specifiedNot specifiedNot specified
94Republic of PolandGovernmentBristol-Myers SquibbRezolstaDarunavir+Cobicistat800mg+150mg tab14.1666600030424.982200934956Not specifiedNot specifiedNot specified
95Republic of PolandGovernmentBristol-Myers SquibbRezolstaDarunavir+Cobicistat800mg+150mg tab14.166300030424.9810042498Not specifiedNot specifiedNot specified
96Republic of LatviaGovernmentJanssen-Cilag Internarional NVRezolstaDarunavir+Cobicistat800mg+150mg tab15.62373030468.711468.71Not specifiedNot specifiedNot specified
97Republic of LithuaniaGovernmentJanssen-Cilag Internarional NVRezolstaDarunavir+Cobicistat800mg+150mg tab17.29873030518.961518.96Not specifiedNot specifiedNot specified
98Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine125mg caps0.9523379203028.57126436112.482015Not specifiedNot specifiedNot specified
99Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps5.61473030168.441168.44Not specifiedNot specifiedNot specified
100Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.DidanosineDidanosine250mg caps0.9503174903028.5158316621.33YesYesNot specified
101Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.733318903022631386VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
102GeorgiaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.666718003020601200partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
103Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine400mg caps1.40113008303042.03433611822462.882015Not specifiedNot specifiedNot specified
104Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine250mg caps1.12874755003033.86158505366812015Not specifiedNot specifiedNot specified
105Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine2g powder1743721174372743242015Not specifiedNot specifiedNot specified
106Republic of KazakhstanGovernmentRanbaxy Laboratories LimitedDidanosine100mg tab0.02452826000601.4747100692372015Not specifiedNot specifiedNot specified
107Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine250mg caps0.4480301216192VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
108Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine400mg caps1.39217098503041.76569952380111.252015Not specifiedNot specifiedNot specified
109Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine250mg caps1.1285157603033.8417192581777.252015Not specifiedNot specifiedNot specified
110Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.531800305251060556500Not specifiedNot specifiedNot specified
111Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.557000305251900997500Not specifiedNot specifiedNot specified
112Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab0.017760000300.5320001060Not specifiedNot specifiedNot specified
113Republic of BelarusGlobal FundViiV HealthcareDolutegravir (as sodium salt)50mg tab5.433330003016310016300IDA Foundation20152015-12-072016-05-28Not specifiedNot specifiedNot specified
114UkraineGovernmentViiV HealthcareDolutegravir (as sodium salt)50mg tab6.83572478030205.07826169387.812016Not specifiedNot specifiedNot specified
115Republic of BelarusGlobal FundViiV HealthcareDolutegravir (as sodium salt)50mg tab5.433330003016310016300IDA Foundation20152015-12-072016-04-19Not specifiedNot specifiedNot specified
116Republic of PolandGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab17.51500030525500262500Not specifiedNot specifiedNot specified
117Republic of LatviaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab20.72633030621.791621.79Not specifiedNot specifiedNot specified
118Republic of LithuaniaGovernmentViiv Healthcare UK LimitedTivicayDolutegravir (as sodium salt)50mg tab24.6693030740.071740.07Not specifiedNot specifiedNot specified
119Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.11200030783400313200Not specifiedNot specifiedNot specified
120Republic of LatviaGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab32.4843030974.521974.52Not specifiedNot specifiedNot specified
121Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.1450003078315001174500Not specifiedNot specifiedNot specified
122Republic of PolandGovernmentViiv Healthcare UK LimitedTRIUMEQDolutegravir+Abacavir/Lamivudine50mg+600mg+300mg tab26.11350030783450352350Not specifiedNot specifiedNot specified
123Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz200mg tab3.2467450090292.25014610Not specifiedNot specifiedNot specified
124Russian FederationGovernmentMerck Sharp & DohmeStocrinEfavirenz200mg tab0.22291726209020.06191838475.082015Not specifiedNot specifiedNot specified
125Republic of UzbekistanGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.112330303.3713.37Not specifiedNot specifiedNot specified
126UkraineGovernmentStrides Arcolab LimitedEfavirenz600mg tab0.11072127180303.3270906235407.922016Not specifiedNot specifiedNot specified
127Republic of ArmeniaGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.10332340909.326241.8VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-11Not specifiedNot specifiedNot specified
128Kyrgyz RepublicGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103389370909.39939234.9UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
129Russian FederationGovernmentPharmasyntezRegastEfavirenz100mg tab0.075227370302.25757917052.752015Not specifiedNot specifiedNot specified
130Republic of KazakhstanGovernmentRanbaxy Laboratories LimitedEfavirenz600mg tab0.08423741100302.527913701994252.382015Not specifiedNot specifiedNot specified
131Republic of TajikistanGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103390909.319.3Not specifiedNot specifiedNot specified
132Republic of KazakhstanGovernmentZhangjiagang Huachang Pharmaceutical Industry Limited Company, ChinaEfavirenz200mg tab0.0162624400901.442916041990.42015Not specifiedNot specifiedNot specified
133Republic of MoldovaGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.1436136809012.921521963.84IDA Foundation2015Not specifiedYesNot specified
134Republic of LithuaniaGovernmentGreat BritainStocrinEfavirenz600mg tab2.4883303074.65174.65Merck Sharp & Dohme LtdNot specifiedYesNot specified
135Republic of PolandGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab5.853900030175.51300228150Not specifiedNot specifiedNot specified
136Republiс of AzerbaijanGovernmentStrides Arcolab LimitedEfavirenz50mg caps0.4467379503013.4126516951YesYesNot specified
137Republic of BelarusGovernmentHetero Labs + ФарматехEfavirenz600mg tab0.705712765003021.1742550900783.5Фарматех ЗАО2015Not specifiedNot specifiedNot specified
138Republic of MoldovaGovernmentRanbaxy Laboratories LimitedAviranzEfavirenz200mg tab0.0811250907.2125900Dita Estfarm SRL2015Not specifiedNot specifiedYes
139GeorgiaGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.1063867960303.192893292293.08partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
140Russian FederationGovernmentPharmasyntezRegastEfavirenz600mg tab0.4353145377003013.064845906328745.52015Not specifiedNot specifiedNot specified
141Republiс of AzerbaijanGovernmentStrides Arcolab LimitedEfavirenz600mg tab0.4596264003013.7720880287517.59YesYesNot specified
142Russian FederationGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab0.2422123790307.2670793513957.192015Not specifiedNot specifiedNot specified
143Republic of UzbekistanGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103390909.319.3Not specifiedNot specifiedNot specified
144UkraineGlobal FundHetero labs Ltd.Efavirenz600mg tab0.102330303.0713.072015Not specifiedNot specifiedNot specified
145Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEfavirenz600mg tab0.116721000303.57002450VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
146Russian FederationGovernmentPharmasyntezRegastEfavirenz600mg tab0.4353145377003013.064845906328745.52015Not specifiedNot specifiedNot specified
147Republic of EstoniaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab1.7573303052.72152.72Not specifiedNot specifiedNot specified
148UkraineGovernmentStrides Arcolab LimitedEfavirenz200mg tab0.1172924309010.55102710834.852016Not specifiedNot specifiedNot specified
149Kyrgyz RepublicGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.1167-303.5--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
150GeorgiaGlobal FundStrides Arcolab LimitedEfavirenz200mg tab0.103332400909.33603348partnership for supply. chain management (PFSCM)2015Not specifiedYesNot specified
151Republic of KazakhstanGovernmentMerck Sharp & DohmeEfavirenz50mg tab0.6669750---460352015Not specifiedNot specifiedNot specified
152Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDEfavirenz600mg tab0.14415000304.325002160IDA Foundation2015Not specifiedYesNot specified
153Republic of MoldovaGovernmentHetero labs Ltd.EstivaEfavirenz600mg tab0.250366420307.51221416627.14Sanfarm-Prim SA2015Not specifiedNot specifiedNot specified
154Republiс of AzerbaijanGovernmentStrides Arcolab LimitedEfavirenz200mg tab0.2588190809023.292124937.48YesYesNot specified
155Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDEfavirenz600mg tab0.14415000304.3250021602015Not specifiedNot specifiedNot specified
156Republic of KazakhstanGovernmentZhangjiagang Huachang Pharmaceutical Industry Limited Company, ChinaEfavirenz600mg tab0.085379800302.5512660322832015Not specifiedNot specifiedNot specified
157Republic of LatviaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab1.388303041.64141.64Not specifiedNot specifiedNot specified
158Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Efavirenz50mg caps0.15372130304.6171327.31IDA Foundation2015Not specifiedYesNot specified
159Republic of LithuaniaGovernmentMerck Sharp & DohmeStocrinEfavirenz600mg tab2.351303070.53170.53Not specifiedYesNot specified
160Republic of TajikistanGlobal FundStrides Arcolab LimitedEfavirenz600mg tab0.112330303.3713.37Not specifiedNot specifiedNot specified
161Russian FederationGovernmentARS PharmEfavirenzEfavirenz200mg tab0.24972850307.4995711.552015Not specifiedNot specifiedNot specified
162Republic of PolandGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabin+Tenofovir Disoproxil600mg+200mg+245mg tab26.436600030793.08200158616Not specifiedNot specifiedNot specified
163Republic of PolandGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabin+Tenofovir Disoproxil600mg+200mg+245mg tab26.436900030793.08300237924Not specifiedNot specifiedNot specified
164Republiс of AzerbaijanGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab1.3264089603039.7813632542280.94YesYesNot specified
165Republic of BelarusGovernmentHetero Labs + ФарматехEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab2.8033990003084.13300277530Фарматех ЗАО2015Not specifiedNot specifiedNot specified
166Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.324721960309.747327129.68VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
167Republic of TajikistanGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.375303011.25111.25Not specifiedNot specifiedNot specified
168Republic of MoldovaGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.353875403010.59291830901.62IDA Foundation2015Not specifiedYesNot specified
169Kyrgyz RepublicGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.3752322903011.25774387108.75UNDP/UNICEF2015Not specifiedNot specifiedNot specified
170Republic of MoldovaGlobal FundHetero labs Ltd.Efavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.353875103010.59291730891.032015Not specifiedNot specifiedNot specified
171UkraineGovernmentMerck Sharp & DohmeEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab1.16373504603034.9111682407818.622016Not specifiedNot specifiedNot specified
172Republic of MoldovaGovernmentRanbaxy Laboratories LimitedAviroday MEEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab0.454302003013.514340193590Dita Estfarm SRL2015Not specifiedNot specifiedYes
173UkraineGlobal FundMerck Sharp & DohmeEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab13030301302015Not specifiedNot specifiedNot specified
174Republic of PolandGovernmentGilead SciencesAtriplaEfavirenz+Emtricitabine+Tenofovir - FDC600mg+200mg+300mg tab26.4369150030793.0830502418894Not specifiedNot specifiedNot specified
175Republic of PolandGovernmentBristol-Myers SquibbStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab29.1667510003087517001487500Not specifiedNot specifiedNot specified
176Republic of PolandGovernmentBristol-Myers SquibbStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab29.1667750003087525002187500Not specifiedNot specifiedNot specified
177Republic of PolandGovernmentBristol-Myers SquibbStribildElvitegravis+Cobicistat+Emtricitabin+Tenofovir Disoproxil150mg+150mg+200mg+245mg tab29.166733000308751100962500Not specifiedNot specifiedNot specified
178Republic of PolandGovernmentGilead SciencesEmtrivaEmtricitabine200mg caps8.3293210030249.887017491.6Not specifiedNot specifiedNot specified
179Republic of PolandGovernmentGilead SciencesEmtrivaEmtricitabine200mg caps8.3293180030249.886014992.8Not specifiedNot specifiedNot specified
180Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab26.77337350030803.224501967840Not specifiedNot specifiedNot specified
181Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab26.773320100030803.267005381440Not specifiedNot specifiedNot specified
182Russian FederationGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+300mg+25mg tab29.51032094030885.31698617946.382015Not specifiedNot specifiedNot specified
183Republic of PolandGovernmentGilead SciencesEvipleraEmtricitabine+Rilpivirine+Tenofovir200mg+25mg+245mg tab26.77333000030803.21000803200Not specifiedNot specifiedNot specified
184Kyrgyz RepublicGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.2003-306.01--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
185Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.223333120306.711047396.82015Not specifiedNot specifiedNot specified
186Republic of BelarusGovernmentHetero Labs + ФарматехEmtricitabine+Tenofovir - FDC200mg+300mg tab2.34933176103070.4810587746171.75Фарматех ЗАО2015Not specifiedNot specifiedNot specified
187Republic of KazakhstanGovernmentGilead SciencesEmtricitabine+Tenofovir - FDC200mg+300mg tab0.11877237800303.56241260858885.622015Not specifiedNot specifiedNot specified
188Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.17920220305.376743619.38VPP, through Partnership for Supply Chain Management (PFSCM)20152016-03-112015-10-14Not specifiedNot specifiedNot specified
189GeorgiaGlobal FundHetero labs Ltd.Emtricitabine+Tenofovir - FDC200mg+300mg tab0.1973824040305.9227468162610.56partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
190Republic of LatviaGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+245mg tab15.64273030469.281469.28Not specifiedNot specifiedNot specified
191Republic of TajikistanGlobal FundHetero labs Ltd.Emtricitabine+Tenofovir - FDC200mg+300mg tab0.200330306.0116.01Not specifiedNot specifiedNot specified
192Republic of PolandGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+245mg tab17.269318150030518.0860503134384Not specifiedNot specifiedNot specified
193Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDEmtricitabine+Tenofovir - FDC200mg+300mg tab0.223333120306.711047396.8IDA Foundation2015Not specifiedYesNot specified
194Russian FederationGovernmentGilead SciencesTruvadaEmtricitabine+Tenofovir - FDC200mg+300mg tab6.97339897030209.23299690150.812015Not specifiedNot specifiedNot specified
195UkraineGlobal FundMacleods Pharmaceuticals LtdEmtricitabine+Tenofovir - FDC200mg+300mg tab0.178730305.3615.362015Not specifiedNot specifiedNot specified
196Republic of PolandGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml27.7512006016652033300Not specifiedNot specifiedNot specified
197Republic of LatviaGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml24.557760601473.4611473.46Not specifiedNot specifiedNot specified
198Russian FederationGovernmentRocheFuzeonEnfuvirtide108mg/ml infusion solution 1 ml18.170326940601090.22449489508.782015Not specifiedNot specifiedNot specified
199Republic of PolandGovernmentJohnson & JohnsonIntelenceEtravirine200mg tab6.69151800060401.49300120447Not specifiedNot specifiedNot specified
200GeorgiaGlobal FundJanssenEtravirine100mg tab4.791757601205754827600partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
201Republic of LatviaGovernmentJohnson & JohnsonIntelenceEtravirine100mg tab3.5232120120422.791422.79Not specifiedNot specifiedNot specified
202UkraineGovernmentJanssenEtravirine100mg tab2.892223880120347.0619969064.942016Not specifiedNot specifiedNot specified
203Russian FederationGovernmentJohnson & JohnsonIntelenceEtravirine100mg tab2.7487454440120329.85378712491422015Not specifiedNot specifiedNot specified
204Republic of PolandGovernmentJohnson & JohnsonIntelenceEtravirine200mg tab6.69154050060401.49675271005.75Not specifiedNot specifiedNot specified
205Russian FederationGovernmentJohnson & JohnsonIntelenceEtravirine200mg tab5.4245279966060325.4746661151867562015Not specifiedNot specifiedNot specified
206Russian FederationGovernmentViiV HealthcareTelzirFosamprenavir50mg/ml oral solution 225ml60.212608160.212608157027.692015Not specifiedNot specifiedNot specified
207Republic of LatviaGovernmentViiV HealthcareTelzirFosamprenavir700mg tab4.87336060292.41292.4Not specifiedNot specifiedNot specified
208Russian FederationGovernmentViiV HealthcareTelzirFosamprenavir700mg tab3.3357214368060200.143572871506022015Not specifiedNot specifiedNot specified
209UkraineGovernmentCipla LtdLamivudine10mg/ml oral solution 100ml0.0179259610.017925967925.962016Not specifiedNot specifiedNot specified
210Russian FederationGovernmentPharmasyntezAmivirenLamivudine300mg tab0.30774079520309.231359841255132.382015Not specifiedNot specifiedNot specified
211Republic of KazakhstanGovernmentRanbaxy Laboratories LimitedLamivudine150mg tab0.0312740400601.82123403822122015Not specifiedNot specifiedNot specified
212Republic of UzbekistanGlobal FundCipla LtdLamivudine10mg/ml oral solution 100ml2.2-12.2--Not specifiedNot specifiedNot specified
213Republic of PolandGovernmentLimited t/a MylanLamivudineLamivudine150mg tab0.88131380006052.882300121624Not specifiedNot specifiedNot specified
214Russian FederationGovernmentVialLamivudine-VialLamivudine150mg tab0.38474192206023.086987161259.952015Not specifiedNot specifiedNot specified
215Republic of KazakhstanGovernmentViiV HealthcareLamivudine150mg tab0.0313288000601.88480090242015Not specifiedNot specifiedNot specified
216Republic of EstoniaGovernmentViiV HealthcareEpivirLamivudine150mg tab3.39026060203.411203.41Not specifiedNot specifiedNot specified
217Republic of TajikistanGlobal FundHetero labs Ltd.Lamivudine10mg/ml oral solution 100ml1.2-11.2--Not specifiedNot specifiedNot specified
218Russian FederationGovernmentHetero labs Ltd.Heptavir 150Lamivudine150mg tab0.06471604940603.8826749103786.122015Not specifiedNot specifiedNot specified
219Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Lamivudine10mg/ml oral solution 240ml2.35-12.35--Not specifiedNot specifiedNot specified
220UkraineGlobal FundSun Pharmaceutical Industries LimitedLamivudine150mg tab0.033760602.0212.022015Not specifiedNot specifiedNot specified
221Republic of MoldovaGovernmentRanbaxy Laboratories LimitedAvolamLamivudine150mg tab0.0512000603200600Dita Estfarm SRL2015YesNot specifiedNot specified
222Republic of LithuaniaGovernmentMerck Sharp & DohmeZeffixLamivudine100mg tab2.6661282874.65174.65Not specifiedNot specifiedNot specified
223Kyrgyz RepublicGlobal FundHetero labs Ltd.Lamivudine150mg tab0.0383-602.3--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
224Russian FederationGovernmentViiV HealthcareEpivirLamivudine10mg/ml oral solution 240ml30.5744581130.57445811362841.122015Not specifiedNot specifiedNot specified
225Republic of KazakhstanGovernmentViiV HealthcareEpivirLamivudine10mg/ml oral solution 240ml24.663740124.66374092228.42015Not specifiedNot specifiedNot specified
226Republic of LatviaGovernmentViiV HealthcareEpivirLamivudine300mg tab5.24273030157.281157.28Not specifiedNot specifiedNot specified
227Republic of PolandGovernmentViiV HealthcareEpivirLamivudine10mg/ml oral solution 240ml47.5450147.545021375Not specifiedNot specifiedNot specified
228UkraineGovernmentAurobindo Pharma Ltd.Lamivudine150mg tab0.04032190960602.423651688368.722016Not specifiedNot specifiedNot specified
229Russian FederationGovernmentPharmasyntezAmivirenLamivudine150mg tab0.055322779840603.323796641260484.52015Not specifiedNot specifiedNot specified
230Republic of KazakhstanGovernmentJSC Nobel Almaty Pharmaceutical FactoryLamivudine100mg tab0.023239400601.3839905506.22015Not specifiedNot specifiedNot specified
231Russian FederationGovernmentViiV HealthcareEpivirLamivudine150mg tab0.34351374006020.61229047196.92015Not specifiedNot specifiedNot specified
232Republic of BelarusGovernmentHetero Labs + ФарматехLamivudine150mg tab0.52378365806031.4213943438089.06Фарматех ЗАО2015Not specifiedNot specifiedNot specified
233Republic of UzbekistanGlobal FundHetero labs Ltd.Lamivudine150mg tab0.03960602.3412.34Not specifiedNot specifiedNot specified
234Russian FederationGovernmentAurobindo Pharma Ltd.LamivudineLamivudine150mg tab0.16337787220609.81297871271912.622015Not specifiedNot specifiedNot specified
235Republic of KazakhstanGovernmentViiV HealthcareLamivudine100mg tab0.0251747200601.529120436802015Not specifiedNot specifiedNot specified
236Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.Lamivudine10mg/ml oral solution 240ml8.1453318.145334338.62YesYesNot specified
237Republic of MoldovaGovernmentViiv Healthcare UK LimitedEpivirLamivudine10mg/ml oral solution 240ml31.56344131.5634410856.64Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
238Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine10mg/ml oral solution 240ml10.6915110.6915160.35IDA Foundation2015Not specifiedYesNot specified
239Republic of TajikistanGlobal FundViiV HealthcareLamivudine150mg tab0.038360602.312.3Not specifiedNot specifiedNot specified
240Republiс of AzerbaijanGovernmentAurobindo Pharma Ltd.Lamivudine150mg tab0.1945343206011.675726675.24YesYesNot specified
241Republic of ArmeniaGlobal FundHetero labs Ltd.Lamivudine10mg/ml oral solution 240ml1.533911.533959.67VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
242GeorgiaGlobal FundAurobindo Pharma Ltd.Lamivudine150mg tab0.035832400602.155401161partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
243Kyrgyz RepublicGlobal FundHetero labs Ltd.Lamivudine100mg tab0.0383-602.3--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
244Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDLamivudine150mg tab0.033321006023570VPP, through Partnership for Supply Chain Management (PFSCM)20152016-03-112015-10-14Not specifiedNot specifiedNot specified
245Republic of LatviaGovernmentViiV HealthcareEpivirLamivudine10mg/ml oral solution 240ml38.04-138.04--Not specifiedNot specifiedNot specified
246GeorgiaGlobal FundHetero labs Ltd.Lamivudine10mg/ml oral solution 240ml1.9540011.95400780partnership for supply. chain management (PFSCM)2015Not specifiedNot specifiedNot specified
247Republic of TajikistanGlobal FundMatrixLamivudine+Nevirapine+Zidovudine - FDC30mg+50mg+60mg tab0.060860603.6513.65Not specifiedNot specifiedNot specified
248Republic of ArmeniaGlobal FundCipla LtdLamivudine+Nevirapine+Zidovudine - FDC150mg+200mg+300mg tab0.13915840608.342642201.76VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
249Republic of MoldovaGovernmentRanbaxy Laboratories LimitedAvocomb NLamivudine+Nevirapine+Zidovudine - FDC150mg+200mg+300mg tab0.1913148680305.74495628447.44Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
250Republic of TajikistanGlobal FundCipla LtdLamivudine+Nevirapine+Zidovudine - FDC150mg+200mg+300mg tab0.156760609.419.4Not specifiedNot specifiedNot specified
251Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine+Nevirapine+Zidovudine - FDC150mg+200mg+300mg tab0.154319260609.263212972.462015Not specifiedYesNot specified
252Russian FederationGovernmentHetero labs Ltd.Zidolam-NLamivudine+Nevirapine+Zidovudine - FDC300mg+200mg+150mg tab0.95421410606057.252351134594.752015Not specifiedNot specifiedNot specified
253UkraineGovernmentHetero labs Ltd.Lamivudine+Tenofovir - FDC300mg tab0.40735063703012.2216879206261.382016Not specifiedNot specifiedNot specified
254Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine+Tenofovir - FDC300mg tab0.183322980305.57664213IDA Foundation2015Not specifiedNoNot specified
255Republic of MoldovaGovernmentRanbaxy Laboratories LimitedTenalemLamivudine+Tenofovir - FDC300mg tab0.226333840306.7911287659.12Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
256Republic of UzbekistanGlobal FundMYLAN LABORATORIES LTDLamivudine+Tenofovir - FDC300mg tab0.173330305.215.2Not specifiedNot specifiedNot specified
257Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine+Tenofovir - FDC300mg tab0.183322980305.576642132015Not specifiedNot specifiedNot specified
258Republic of TajikistanGlobal FundViiV HealthcareLamivudine+Zidovudine 150mg+300mg tab0.118360607.117.1Not specifiedNot specifiedNot specified
259Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine+Zidovudine 150mg+300mg tab0.123737680607.426284659.762015Not specifiedNot specifiedNot specified
260Republic of BelarusGovernmentHetero Labs + ФарматехLamivudine+Zidovudine 150mg+300mg tab0.24325686606014.5842811624184.38Фарматех ЗАО2015Not specifiedNot specifiedNot specified
261Republic of LatviaGovernmentViiV HealthcareCombivirLamivudine+Zidovudine 150mg+300mg tab0.9232606055.39155.39Not specifiedNot specifiedNot specified
262Republic of EstoniaGovernmentViiV HealthcareCombivirLamivudine+Zidovudine 150mg+300mg tab4.91876060295.121295.12Not specifiedNot specifiedNot specified
263Republic of LithuaniaGovernmentЛех АноCombivirLamivudine+Zidovudine 150mg+300mg tab2.57176060154.31154.3Not specifiedNot specifiedNot specified
264Russian FederationGovernmentHetero labs Ltd.ZidolamLamivudine+Zidovudine 150mg+300mg tab0.3568119438406021.4119906442619602015Not specifiedNot specifiedNot specified
265Republic of MoldovaGlobal FundHetero labs Ltd.Lamivudine+Zidovudine 150mg+300mg tab0.123737740607.426294667.18IDA Foundation2015Not specifiedYesNot specified
266Republic of MoldovaGovernmentHetero labs Ltd.ZidolamLamivudine+Zidovudine 150mg+300mg tab0.2051320006012.3220027060Sanfarm-Prim SA2015Not specifiedNot specifiedNot specified
267Republic of LithuaniaGovernmentTeva BVLamivudine+Zidovudine 150mg+300mg tab2.57176060154.31154.3Not specifiedNot specifiedNot specified
268UkraineGovernmentMatrixLamivudine+Zidovudine 30mg+60mg tab0.041754600602.591022752016Not specifiedNot specifiedNot specified
269Russian FederationGovernmentRanbaxy Laboratories LimitedVirocombLamivudine+Zidovudine 150mg+300mg tab0.528563583806031.711059733360403.752015Not specifiedNot specifiedNot specified
270Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDLamivudine+Zidovudine 150mg+300mg tab0.1149380606.68235431.8VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
271UkraineGlobal FundHetero labs Ltd.Lamivudine+Zidovudine 150mg+300mg tab0.104260606.2516.252015Not specifiedNot specifiedNot specified
272Republic of KazakhstanGovernmentViiV HealthcareLamivudine+Zidovudine 150mg+300mg tab0.051298622000603.07164370050461592015Not specifiedNot specifiedNot specified
273Republic of TajikistanGlobal FundMatrixLamivudine+Zidovudine 30mg+60mg tab0.031760601.911.9Not specifiedNot specifiedNot specified
274Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDLamivudine+Zidovudine 30mg+60mg tab0.0478220602.82137386.342015Not specifiedNot specifiedNot specified
275Republic of PolandGovernmentCipla LtdLAZIVIRLamivudine+Zidovudine 150mg+300mg tab0.27051200006016.23200032460Not specifiedNot specifiedNot specified
276Kyrgyz RepublicGlobal FundHetero labs Ltd.Lamivudine+Zidovudine 150mg+300mg tab0.1152-606.91--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
277Republic of LithuaniaGovernmentViiv Healthcare UK LimitedCombivirLamivudine+Zidovudine 150mg+300mg tab2.57176060154.31154.3Not specifiedNot specifiedNot specified
278Russian FederationGovernmentPharmasyntezDizaveroxLamivudine+Zidovudine 150mg+300mg tab0.3738171549006022.432859156413073.52015Not specifiedNot specifiedNot specified
279UkraineGovernmentAurobindo Pharma Ltd.Lamivudine+Zidovudine 150mg+300mg tab0.10575853900606.3497565618562.122016Not specifiedNot specifiedNot specified
280Republic of KazakhstanGovernmentMYLAN LABORATORIES LTDLamivudine+Zidovudine 150mg+300mg tab0.03327846000601.984641009189182015Not specifiedNot specifiedNot specified
281Russian FederationGovernmentViiV HealthcareCombivirLamivudine+Zidovudine 150mg+300mg tab0.59451580406035.67263493954.782015Not specifiedNot specifiedNot specified
282GeorgiaGlobal FundRanbaxy Laboratories LimitedLamivudine+Zidovudine 150mg+300mg tab0.1058681120606.351135272085.2partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified
283Republic of LatviaGovernmentTeva BVLamivudine / Zidovudine TevaLamivudine+Zidovudine 150mg+300mg tab0.9232606055.39155.39Not specifiedNot specifiedNot specified
284Republiс of AzerbaijanGovernmentViiV HealthcareCombivirLamivudine+Zidovudine 150mg+300mg tab0.41884374006025.137290183197.7YesYesNot specified
285Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDLamivudine+Zidovudine 30mg+60mg tab0.0478220602.82137386.342015Not specifiedNot specifiedNot specified
286Republic of UzbekistanGlobal FundMYLAN LABORATORIES LTDLamivudine+Zidovudine 150mg+300mg tab0.118360607.117.1Not specifiedNot specifiedNot specified
287Kyrgyz RepublicGlobal FundCipla LtdLopinavir+Ritonavir - FDC200mg+50mg tab0.2083-12025--UNDP/UNICEF2015Not specifiedNot specifiedNot specified
288Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506712000012060.8100060800UNICEF Supply Division20152015-11-042016-01-30Not specifiedNot specifiedNot specified
289UkraineGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506712012060.8160.82015Not specifiedNot specifiedNot specified
290Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml81.46855407.341407.34Not specifiedNot specifiedNot specified
291Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.4292480060205.758016460Not specifiedNot specifiedNot specified
292Russian FederationGovernmentAbbottKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.724894344060103.49157241627276.752015Not specifiedNot specifiedNot specified
293Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506784816012060.87068429734.41UNICEF Supply Division20152015-11-252016-03-01Not specifiedNot specifiedNot specified
294GeorgiaGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16255560.8513100.8partnership for supply. chain management (PFSCM)2015NoYesNot specified
295Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.71376060102.821102.82Not specifiedNot specifiedNot specified
296Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.42921260000120411.5105004320750Not specifiedNot specifiedNot specified
297Republic of MoldovaGovernmentAbbVieAluviaLopinavir+Ritonavir - FDC200mg+50mg tab0.577134200012069.252850197362.5Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
298Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.3937120120407.251407.25Not specifiedYesNot specified
299Republic of MoldovaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506717004012060.8141786153.62015Not specifiedNot specifiedNot specified
300GeorgiaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506745144012060.83762228729.59partnership for supply. chain management (PFSCM)2015YesNot specifiedNot specified
301Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml61.837553097523175Not specifiedNot specifiedNot specified
302UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml0.236100717051.18201434237692.122016Not specifiedNot specifiedNot specified
303Republic of EstoniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml88.762-5443.81--Not specifiedNot specifiedNot specified
304Republic of KazakhstanGovernmentAesica Queenborough Limited, Great BritainLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml2.37211175511.86223526507.12015Not specifiedNot specifiedNot specified
305Republic of MoldovaGlobal FundAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.3497144006020.982405035.22015Not specifiedNot specifiedNot specified
306Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Lopinavir+Ritonavir - FDC200mg+50mg tab0.506712012060.8160.8Not specifiedNot specifiedNot specified
307Republic of UzbekistanGlobal FundAesica Queenborough Limited, Great BritainLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16-560.8--Not specifiedNot specifiedNot specified
308UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.54181303212012065.0210860170612372016Not specifiedNot specifiedNot specified
309Republic of ArmeniaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.50678460012060.870542864VPP, through Partnership for Supply Chain Management (PFSCM)20152015-05-112015-10-14Not specifiedNot specifiedNot specified
310Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.4291240000120411.492000822980Not specifiedNot specifiedNot specified
311Russian FederationGovernmentAbbottKaletraLopinavir+Ritonavir - FDC200mg+50mg tab1.050882860720120126.1690506870728082015Not specifiedNot specifiedNot specified
312Kyrgyz RepublicGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg/ml+20mg/ml oral solution 100ml12.16-560.8--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
313Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506718000012060.8150091200UNICEF Supply Division20152015-11-192016-02-17Not specifiedNot specifiedNot specified
314Republiс of AzerbaijanGovernmentAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab1.2519495360120150.234128620149.44YesYesNot specified
315Republic of TajikistanGlobal FundAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.128360607.717.7Not specifiedNot specifiedNot specified
316Republic of LatviaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab2.9628120120355.541355.54Not specifiedNot specifiedNot specified
317Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml61.7982505308.995015449.5Not specifiedNot specifiedNot specified
318Republiс of AzerbaijanGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml42.09821005210.4942088405.8YesYesNot specified
319Republic of MoldovaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml13.85510113.855107063.5Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
320Republic of MoldovaGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.506717016012060.8141886214.4IDA Foundation2015Not specifiedYesNot specified
321Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab1.69686060101.811101.81Not specifiedYesNot specified
322Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC100mg+25mg tab3.42921500060205.7525051437.5Not specifiedNot specifiedNot specified
323Republic of KazakhstanGovernmentAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.007885190400600.471419840667324.812015Not specifiedNot specifiedNot specified
324Republic of LithuaniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml74.576-5372.88--2015Not specifiedYesNot specified
325Republic of MoldovaGlobal FundAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.3497139206020.982324867.362015Not specifiedNot specifiedNot specified
326Republic of TajikistanGlobal FundAbbVieKaletraLopinavir+Ritonavir - FDC80mg+20mg oral solution 60ml12.16-560.8--Not specifiedNot specifiedNot specified
327Republic of PolandGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.4264180000120411.171500616755Not specifiedNot specifiedNot specified
328Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Lopinavir+Ritonavir - FDC200mg+50mg tab0.02811201203.3713.37Not specifiedNot specifiedNot specified
329UkraineGovernmentAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.270813014606016.2521691352478.752016Not specifiedNot specifiedNot specified
330Republic of EstoniaGovernmentAbbVieKaletraLopinavir+Ritonavir - FDC200mg+50mg tab3.6984120120443.811443.81Not specifiedNot specifiedNot specified
331Republic of BelarusGlobal FundAbbVieLopinavir+Ritonavir - FDC200mg+50mg tab0.50674980012060.841525232UNICEF Supply Division20152015-12-222016-03-01Not specifiedNot specifiedNot specified
332Republic of KazakhstanGovernmentAbbVieLopinavir+Ritonavir - FDC100mg+25mg tab0.00224428000600.137380095942015Not specifiedNot specifiedNot specified
333Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc150mg tab14.1667720060850120102000Not specifiedNot specifiedNot specified
334Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc150mg tab14.16672400608504034000Not specifiedNot specifiedNot specified
335Republic of LatviaGovernmentViiV HealthcareCelsentriMaraviroc300mg tab12.85236060771.141771.14Not specifiedNot specifiedNot specified
336Russian FederationGovernmentViiV HealthcareCelsentriMaraviroc300mg tab6.86221560060411.73260107049.82015Not specifiedNot specifiedNot specified
337Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc300mg tab14.166760006085010085000Not specifiedNot specifiedNot specified
338Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc300mg tab14.16671440060850240204000Not specifiedNot specifiedNot specified
339Republic of PolandGovernmentViiV HealthcareCelsentriMaraviroc300mg tab14.16674800608508068000Not specifiedNot specifiedNot specified
340Russian FederationGovernmentViiV HealthcareCelsentriMaraviroc150mg tab3.8402312060230.415211981.322015Not specifiedNot specifiedNot specified
341Republic of PolandGovernmentCipla LtdViramuneNevirapine (NVP)400mg tab1.7917750003053.752500134375Not specifiedNot specifiedNot specified
342Republic of MoldovaGovernmentRanbaxy Laboratories LimitedNevipanNevirapine (NVP)200mg tab0.054330000603.265001630Dita Estfarm SRL2015Not specifiedNot specifiedNot specified
343Republic of KazakhstanGovernmentBoehringer IngelheimNevirapine (NVP)200mg tab0.01031479600600.622466015289.22015Not specifiedNot specifiedNot specified
344Kyrgyz RepublicGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)50mg tab0.04172430301.2581101.25UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
345Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)200mg tab0.06310020603.78167631.262015Not specifiedNot specifiedNot specified
346Republic of TajikistanGlobal FundBoehringer IngelheimNevirapine (NVP)10mg/ml oral solution 240ml1.35-11.35--Not specifiedNot specifiedNot specified
347UkraineGovernmentCipla LtdNevirapine (NVP)10mg/ml oral solution 100ml0.0119000010.0119000019002016Not specifiedNot specifiedNot specified
348Republiс of AzerbaijanGovernmentCipla LtdNevirapine (NVP)10mg/ml oral solution 240ml108011080800YesYesNot specified
349Republic of KazakhstanGovernmentEmcure Pharmaceuticals Ltd.Nevirapine (NVP)200mg tab0.010345568800600.62759480470877.592015Not specifiedNot specifiedNot specified
350Republiс of AzerbaijanGovernmentHetero labs Ltd.Nevirapine (NVP)200mg tab0.19151140606011.49190121842.49YesYesNot specified
351Russian FederationGovernmentDrugs technologyNevirapine-TLNevirapine (NVP)200mg tab0.12421016820607.4516947126255.152015Not specifiedNot specifiedNot specified
352Republic of UzbekistanGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)200mg tab0.0460602.412.4Not specifiedNot specifiedNot specified
353Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)200mg tab0.040860602.4512.45Not specifiedNot specifiedNot specified
354UkraineGlobal FundHetero labs Ltd.Nevirapine (NVP)200mg tab0.041260602.4712.472015Not specifiedNot specifiedNot specified
355Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)200mg tab0.06310020603.78167631.26IDA Foundation2015Not specifiedYesNot specified
356Kyrgyz RepublicGlobal FundStrides Arcolab LimitedNevirapine (NVP)200mg tab0.0375-602.25--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
357Republic of ArmeniaGlobal FundCipla LtdNevirapine (NVP)10mg/ml oral solution 100ml1.258411.2584105VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
358Republic of LatviaGovernmentBoehringer IngelheimViramuneNevirapine (NVP)200mg tab3.08026060184.811184.81Not specifiedNot specifiedNot specified
359Kyrgyz RepublicGlobal FundCipla LtdNevirapine (NVP)10mg/ml oral solution 100ml2.335512.3355128.15UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
360Republic of BelarusGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)10mg/ml oral solution 100ml1.543211.5432648IDA Foundation20152015-12-222016-05-28Not specifiedNot specifiedNot specified
361Republic of UzbekistanGlobal FundCipla LtdNevirapine (NVP)10mg/ml oral solution 100ml1.25-11.25--Not specifiedNot specifiedNot specified
362Republic of KazakhstanGovernmentBoehringer IngelheimViramuneNevirapine (NVP)10mg/ml oral solution 240ml19.764010119.76401079237.62015Not specifiedNot specifiedNot specified
363Republic of MoldovaGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)10mg/ml oral solution 240ml10.5215110.5215157.82015Not specifiedNot specifiedNot specified
364Russian FederationGovernmentBoehringer IngelheimViramuneNevirapine (NVP)10mg/ml oral solution 240ml12.7512170112.7512170155167.52015Not specifiedNot specifiedNot specified
365Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDNevirapine (NVP)200mg tab0.036711460602.2191420.2VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
366UkraineGovernmentStrides Arcolab LimitedNevirapine (NVP)200mg tab0.0417423360602.57056176402016Not specifiedNot specifiedNot specified
367Russian FederationGovernmentPharmasyntezNevirpineNevirapine (NVP)200mg tab0.319827007206019.1945012863780.252015Not specifiedNot specifiedNot specified
368Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Nevirapine (NVP)10mg/ml oral solution 100ml1.25-11.25--Not specifiedNot specifiedNot specified
369Russian FederationGovernmentAZT PHARMA K.B.NikavirPhosphazide400mg tab0.633527445806038.01457431738691.382015Not specifiedNot specifiedNot specified
370Russian FederationGovernmentAZT PHARMA K.B.NikavirPhosphazide200mg tab0.64120723802012.821036191328395.622015Not specifiedNot specifiedNot specified
371Republic of LithuaniaGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab12.00556060720.331720.33Not specifiedNot specifiedNot specified
372Russian FederationGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab9.2565380958060555.3963493352633762015Not specifiedNot specifiedNot specified
373Republic of LatviaGovernmentMerck Sharp & DohmeIsentressRaltegravir100mg tab3.06536060183.921183.92Not specifiedNot specifiedNot specified
374Republic of PolandGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab7.86623000060471.97500235985Not specifiedNot specifiedNot specified
375Republic of BelarusGlobal FundMerck Sharp & DohmeRaltegravir400mg tab13.16673120607905241080IDA Foundation20152015-01-132015-05-22Not specifiedNot specifiedNot specified
376Republic of PolandGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab7.866228800060471.9748002265456Not specifiedNot specifiedNot specified
377UkraineGovernmentMerck Sharp & DohmeRaltegravir400mg tab6.78833534060407.3589239899.72016Not specifiedNot specifiedNot specified
378Republic of LatviaGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab11.03586060662.151662.15Not specifiedNot specifiedNot specified
379Republic of ArmeniaGlobal FundMerck Sharp & DohmeRaltegravir400mg tab18.118060108633258VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
380GeorgiaGlobal FundSchering Plough Central East AGRaltegravir400mg tab14.118720060847.08120101649.6partnership for supply. chain management (PFSCM)2015YesNot specifiedNot specified
381Republic of LatviaGovernmentMerck Sharp & DohmeIsentressRaltegravir25mg tab0.7737606046.42146.42Not specifiedNot specifiedNot specified
382Republic of BelarusGlobal FundMerck Sharp & DohmeRaltegravir400mg tab13.16673600607906047400IDA Foundation20152015-01-132015-04-18Not specifiedNot specifiedNot specified
383Republic of PolandGovernmentMerck Sharp & DohmeIsentressRaltegravir400mg tab7.86627800060471.971300613561Not specifiedNot specifiedNot specified
384Republic of PolandGovernmentJohnson & JohnsonEdurantRilpivirine25mg tab9.16671890030275630173250Not specifiedNot specifiedNot specified
385Republic of PolandGovernmentJohnson & JohnsonEdurantRilpivirine25mg tab9.16671800302756016500Not specifiedNot specifiedNot specified
386Russian FederationGovernmentJohnson & JohnsonEdurantRilpivirine25mg tab17.33733216030520.121072557568.622015Not specifiedNot specifiedNot specified
387Russian FederationGovernmentAbbottNorvirRitonavir (RTV)100mg caps1.062954081009095.66600905748209.52015Not specifiedNot specifiedNot specified
388Republiс of AzerbaijanGovernmentHetero labs Ltd.Ritonavir (RTV)100mg tab2.016757603060.519211616YesYesNot specified
389UkraineGovernmentAbbVieRitonavir (RTV)100mg tab0.914484803027.42161644310.722016Not specifiedNot specifiedNot specified
390GeorgiaGlobal FundAbbVieRitonavir (RTV)100mg tab1.096622803032.88207668258.88partnership for supply. chain management (PFSCM)2015YesNot specifiedNot specified
391Republic of PolandGovernmentAbbVieNorvirRitonavir (RTV)100mg tab0.0903360000302.711200032520Not specifiedNot specifiedNot specified
392Republic of LatviaGovernmentAbbVieNorvirRitonavir (RTV)100mg tab0.748303022.44122.44Not specifiedNot specifiedNot specified
393Republic of BelarusGlobal FundAbbVieRitonavir (RTV)100mg tab0.855216003025.6572018468UNICEF Supply Division20152015-12-222016-05-21Not specifiedNot specifiedNot specified
394Russian FederationGovernmentHetero labs Ltd.Ritonavir-100Ritonavir (RTV)100mg caps0.9443109175406056.66181959103097972015Not specifiedNot specifiedNot specified
395Republic of MoldovaGlobal FundAbbVieRitonavir (RTV)100mg tab0.7193180003021.5860012948IDA Foundation2015Not specifiedYesNot specified
396Republic of MoldovaGlobal FundAbbVieRitonavir (RTV)100mg tab0.7193142503021.5847510250.52015Not specifiedNot specifiedNot specified
397Republic of LithuaniaGovernmentAbbVieNorvirRitonavir (RTV)100mg tab1.0767303032.3132.3Not specifiedNot specifiedNot specified
398Russian FederationGovernmentIrwin 2RinvirRitonavir (RTV)100mg caps1.1163199803033.4966622304.342015Not specifiedNot specifiedNot specified
399Republic of ArmeniaGlobal FundAbbVieRitonavir (RTV)100mg tab1.0966003032.8820657.6VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
400Republic of PolandGovernmentAbbVieNorvirRitonavir (RTV)100mg tab1.45834500003043.7515000656250Not specifiedNot specifiedNot specified
401Republic of PolandGovernmentRocheInviraseSaquinavir500mg tab2.582554000120309.9450139455Not specifiedNot specifiedNot specified
402Russian FederationGovernmentRocheInviraseSaquinavir500mg tab1.5746414600120188.953455652822.252015Not specifiedNot specifiedNot specified
403Republic of LatviaGovernmentRocheInviraseSaquinavir500mg tab2.4327120120291.931291.93Not specifiedNot specifiedNot specified
404Republic of PolandGovernmentRocheInviraseSaquinavir500mg tab2.582518000120309.915046485Not specifiedNot specifiedNot specified
405Russian FederationGovernmentPharmasyntezInterfastSaquinavir500mg tab1.63172237160120195.8186433650299.52015Not specifiedNot specifiedNot specified
406Republic of PolandGovernmentRocheInviraseSaquinavir500mg tab2.5825192000120309.91600495840Not specifiedNot specifiedNot specified
407Russian FederationGovernmentVeropharmVero-StavudineStavudine (d4T)30mg caps0.60057834965633.6313991470517.342015Not specifiedNot specifiedNot specified
408Russian FederationGovernmentHetero labs Ltd.